4.3 Article

Immunoprofiling of cytokines, chemokines, and growth factors in female patients with systemic lupus erythematosus- a pilot study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Roles of IL-1 and IL-10 family cytokines in the progression of systemic lupus erythematosus: Friends or foes?

Yi-Rou Wu et al.

Summary: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with unknown etiology that affects multiple organ systems. Dysregulation of cytokines, particularly IL-1 and IL-10 families, plays a vital role in immune activation and self-tolerance in the pathogenesis of SLE. These cytokines could be potential targets for therapeutic intervention in SLE.

IUBMB LIFE (2022)

Article Immunology

Effects of combined aerobic and anaerobic exercise training on cytokine profiles in patients with systemic lupus erythematosus (SLE); a randomized controlled trial

Somayeh Hashemi et al.

Summary: The 8-week supervised aerobic and anaerobic training program resulted in decreased inflammatory cytokines in SLE patients, while certain immune regulatory factors increased after the intervention period.

TRANSPLANT IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios

Pintip Ngamjanyaporn et al.

Summary: This study evaluated the roles of MCP-1, EGF, or their ratio as biomarkers of histopathology and response to treatment in LN. MCP-1 increased with disease activity, whereas EGF decreased with low GFR and chronic damage. Urine EGF may be a promising biomarker to predict therapeutic response in LN, with EGF/MCP-1 not improving the prediction of response.

PLOS ONE (2022)

Review Biochemistry & Molecular Biology

A review on the role of chemokines in the pathogenesis of systemic lupus erythematosus

Soudeh Ghafouri-Fard et al.

Summary: Chemokines, a group of low molecular weight cytokines, play important roles in the pathogenesis of systemic lupus erythematosus (SLE) and related complications such as lupus nephritis. Some members of the chemokine family have been more clearly defined in their roles in SLE patients or animal models of the disorder.

CYTOKINE (2021)

Review Rheumatology

Systemic lupus erythematosus: The search for the ideal biomarker

Luis Alonso Gonzalez et al.

Summary: There has been an increasing interest in discovering and validating biomarkers for lupus, but few have been successfully utilized in clinical practice. Further validation in large-scale studies and identification of better biomarkers are needed for diagnosis, monitoring, and predicting disease activity. Novel omics techniques also offer new insights in understanding the molecular basis of lupus and identifying potential therapeutic targets.
Article Rheumatology

Serum cytokine levels associated with myocardial injury in systemic lupus erythematosus

Riette du Toit et al.

Summary: This study identified associations between cytokines and SLE myocardial injury, with IL-18 and IL-1Ra significantly higher in patients with heart damage. IL-1Ra independently predicted different stages of CMR myocardial injury.

RHEUMATOLOGY (2021)

Review Biochemistry & Molecular Biology

Cytokines as Biomarkers in Systemic Lupus Erythematosus: Value for Diagnosis and Drug Therapy

Helena Idborg et al.

Summary: Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease characterized by activation and dysregulation of the immune system. Disturbances in immune pathways and genetic susceptibility are key factors in the development of SLE. Dysregulation of cytokines, particularly interferons, has been extensively studied as potential biomarkers and treatment targets in SLE.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Immunology

Arthritis in systemic lupus erythematosus is characterized by local IL-17A and IL-6 expression in synovial fluid

N. Sippl et al.

Summary: This study found elevated levels of IL-17A and IL-6 in the synovial fluids of patients with lupus arthritis, with a subset of CD4(+) T cells expressing markers associated with Th17 cells. Strong production of IFN-gamma was observed in both CD4(+) and CD8(+) cells, suggesting Th17 involvement in lupus arthritis.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)

Article Medicine, Research & Experimental

Expression profile of PU.1 in CD4+T cells from patients with systemic lupus erythematosus

Nan Xiang et al.

Summary: SLE patients showed increased percentages of CD4(+)PU.1(+)T cells and PU.1 mRNA expression in CD4(+)T cells, with a positive correlation with plasma IL-1β expression. However, there were no significant correlations between PU.1 mRNA expression and major clinical/laboratory parameters of SLE patients.

CLINICAL AND EXPERIMENTAL MEDICINE (2021)

Review Biochemistry & Molecular Biology

Clinical and Immunological Biomarkers for Systemic Lupus Erythematosus

Haitao Yu et al.

Summary: Systemic lupus erythematosus (SLE) is a clinically heterogeneous disease characterized by immune dysfunction. Clinical and immunological biomarkers are crucial for diagnosing, assessing, and controlling SLE, including novel biomarkers discovered through omics research.

BIOMOLECULES (2021)

Review Biochemistry & Molecular Biology

Cytokines and Chemokines Involved in Osteoarthritis Pathogenesis

Vilim Molnar et al.

Summary: Osteoarthritis is a common cause of disability worldwide, affecting all joint tissues equally. The pathogenesis involves low-grade inflammation leading to an imbalance between anabolic and catabolic processes. The complex network of cytokines regulating these processes plays a central role in the development and progression of osteoarthritis, with concentrations of proinflammatory and anti-inflammatory cytokines varying based on disease stage and activity levels.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Editorial Material Medicine, General & Internal

Systemic Lupus Erythematosus

Marianthi Kiriakidou et al.

ANNALS OF INTERNAL MEDICINE (2020)

Article Medicine, Research & Experimental

Cytokine clusters as potential diagnostic markers of disease activity and renal involvement in systemic lupus erythematosus

Joonhong Park et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)

Review Immunology

Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus

Takayuki Katsuyama et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Rheumatology

TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus

Helena Idborg et al.

LUPUS SCIENCE & MEDICINE (2018)

Article Rheumatology

Cytokine profiling in active and quiescent SLE reveals distinct patient subpopulations

John A. Reynolds et al.

ARTHRITIS RESEARCH & THERAPY (2018)

Article Medicine, Research & Experimental

Cytokine and autoantibody clusters interaction in systemic lupus erythematosus

Yovana Pacheco et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2017)

Meeting Abstract Rheumatology

CYTOKINE PROFILES IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS

A. Novikov et al.

ANNALS OF THE RHEUMATIC DISEASES (2016)

Article Medicine, General & Internal

Interleukin 1, Interleukin 6, Interleukin 10, and Tumor Necrosis Factor α in Active and Quiescent Systemic Lupus Erythematosus

Alessandro Cigni et al.

JOURNAL OF INVESTIGATIVE MEDICINE (2016)

Letter Rheumatology

A cell-based bioassay for circulating bioactive IL-17: application to destruction in rheumatoid arthritis

Ndieme Ndongo-Thiam et al.

ANNALS OF THE RHEUMATIC DISEASES (2015)

Article Medicine, General & Internal

New classification criteria for systemic lupus erythematosus correlate with disease activity

Felina Anic et al.

CROATIAN MEDICAL JOURNAL (2014)

Review Immunology

Interleukin-7: Fuel for the autoimmune attack

Hans Dooms

JOURNAL OF AUTOIMMUNITY (2013)

Article Rheumatology

Large-Scale Analysis of Tumor Necrosis Factor α Levels in Systemic Lupus Erythematosus

Corinna E. Weckerle et al.

ARTHRITIS AND RHEUMATISM (2012)

Review Biotechnology & Applied Microbiology

Inflammatory Cytokines in Systemic Lupus Erythematosus

Kim Ohl et al.

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)

Review Immunology

Anticytokine therapies in systemic lupus erythematosus

Antonio La Cava

IMMUNOTHERAPY (2010)

Article Multidisciplinary Sciences

Homeostatic imbalance of regulatory and effector T cells due to IL-2 deprivation amplifies murine lupus

Jens Y. Humrich et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Immunology

Selected angiogenic cytokines in systemic lupus erythematosus patients

Antoni Hrycek et al.

AUTOIMMUNITY (2009)

Review Rheumatology

The search for lupus biomarkers

Chau-Ching Liu et al.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2009)

Review Rheumatology

Review of classification criteria for systemic lupus erythematosus

M Petri

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2005)

Article Immunology

Deficiencies of GM-CSF and interferon γ link inflammation and cancer

T Enzler et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2003)

Article Rheumatology

Serum interleukin-15 is elevated in systemic lupus erythematosus

M Aringer et al.

RHEUMATOLOGY (2001)